retatrutide triple agonist glp-1 gip glucagon #retatrutide is a novel peptide at the receptor, receptor, and receptor. 22-24% weight loss at 48 weeks with a similar tolerability profile to #tirzepatide. @LillyPad #medtwitter #endotwitter https://t.co/duYwW0EcmF Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide

Most peptides discussed in muscle research influence growth hormone pathways rather than directly increasing testosterone

Detailed Protocol

While some individuals may notice subtle improvements in appetite, sleep, or energy shortly after starting treatment, most benefits develop gradually over time as the body responds to the peptides signaling effects

For example, in the SELECT cardiovascular outcome trial studying people with obesity, the extent of weight loss did not correlate with the effects of the drug to reduce heart attack, stroke, and cardiovascular death . Also, another long-acting GLP-1 therapy, albiglutide, [was] withdrawn from the market owing to modest efficacy for reduction of glucose and body weight in people with T2D

Take as directed on the supplement package

Hexarelin is a synthetic growth hormone-releasing peptide with protective effects in the cardiovascular system and nervous system and stimulating effects on growth [1, 2]